RUA Life Sciences (GB:RUA) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
RUA Life Sciences, the company behind the leading implantable polymer Elast-Eon™, has secured a significant new contract worth over £400,000 for a short turnaround textile processing project, with potential for a long-term supply agreement. This project reinforces the company’s reputation for high-quality medical device products and showcases the confidence that major medical firms have in RUA’s offerings. The company, known for its medical device business and patented polymer technology, continues to pursue its vision to enhance patient lives through innovative medical devices.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.

